Published in Ann Oncol on January 01, 2000
Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc (2003) 1.40
Successful treatment of primary central nervous system lymphoma without irradiation in children: single center experience. J Korean Med Sci (2012) 0.93
Ataxia and vision loss: flow cytometric diagnosis of primary central nervous system lymphoma. Br J Ophthalmol (2002) 0.75
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol (2005) 7.03
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol (2005) 3.53
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study. J Clin Oncol (2000) 2.30
Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol (1997) 2.20
Blood pressure values in 1116 French-Canadian children. Can Med Assoc J (1976) 2.03
A hopefully biased pilot survey of physicians' knowledge of the content of drug combinations. Can Med Assoc J (1973) 1.87
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution. Exp Hematol (2000) 1.77
Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol (1997) 1.77
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. J Clin Oncol (2005) 1.70
Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study. Chest (1997) 1.65
Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol (2002) 1.63
Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer (1999) 1.61
Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood (1993) 1.52
The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma Group. Blood (1998) 1.49
Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol (2004) 1.47
[Treatment of lung cancer in the elderly]. Rev Mal Respir (2004) 1.39
Discordant encephalocele in monozygotic twins. Am J Med Genet A (2006) 1.38
Nervous reactions after first dose of terfenadine in adults. Lancet (1989) 1.38
[Treatment of bronchial carcinoma in the elderly]. Rev Mal Respir (2002) 1.37
Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann Oncol (2004) 1.37
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol (1998) 1.37
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial. J Clin Oncol (1998) 1.31
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte). Ann Oncol (1993) 1.29
Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia. J Clin Oncol (1996) 1.27
Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol (1996) 1.27
Percutaneous aspiration and drainage of hydatid cysts in the liver. Radiology (1988) 1.26
Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT). Ann Oncol (2008) 1.24
Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol. Ann Oncol (2005) 1.22
Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87. Hematol Oncol Clin North Am (2000) 1.22
Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas. Br J Cancer (2001) 1.21
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment. Hematol J (2001) 1.20
Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer (2001) 1.18
Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurgery (1998) 1.17
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy. Br J Cancer (2003) 1.14
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT. Bone Marrow Transplant (2013) 1.14
Sarcomas and malignant phyllodes tumours of the breast--a retrospective study. Eur J Cancer (2006) 1.14
New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries. Health Policy Plan (2012) 1.14
Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group. J Clin Oncol (1999) 1.14
The epidemiology of stroke in sickle cell patients in Yaounde, Cameroon. J Neurol Sci (2006) 1.13
[Percutaneous vertebroplasty in the treatment of metastases. Technic and results]. J Radiol (1989) 1.12
Familial aggregation of blood pressure and weight in adoptive families. II. Estimation of the relative contributions of genetic and common environmental factors to blood pressure correlations between family members. Am J Epidemiol (1979) 1.11
Familial aggregation of blood pressure and its components. Pediatr Clin North Am (1978) 1.11
Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol (1997) 1.10
Does nephroblastomatosis influence the natural history and relapse rate in Wilms' tumour? A single centre experience over 11 years. Eur J Cancer (2001) 1.08
Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon. J Neurol Sci (2009) 1.07
Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years. J Clin Oncol (1997) 1.06
Editorial: Young hearts and hypertension. Can Med Assoc J (1974) 1.06
Pulmonary activation of synthetic angiotensin I. Life Sci (1968) 1.06
Spinal cord compression by secondary epi- and intradural metastases in childhood. Childs Nerv Syst (1997) 1.06
Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation. Blood (1991) 1.06
Evaluation of core needle biopsy as a substitute to open biopsy in the diagnosis of soft-tissue masses. Eur J Cancer (2003) 1.05
Impact of measles elimination activities on immunization services and health systems: findings from six countries. J Infect Dis (2011) 1.04
Metformin monitoring. Can Med Assoc J (1978) 1.03
Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making. J Clin Oncol (1998) 1.03
Aortic pulse wave velocity as a marker of cardiovascular disease in subjects over 70 years old. J Hypertens (2001) 1.02
Aorta to coronary artery saphenous vein grafts. Preoperative angiographic criteria for successful surgery. Am J Cardiol (1972) 1.02
Effects of dopamine on myocardial metabolism in patients with ischaemic heart disease. Cardiovasc Res (1973) 1.01
Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres. Ann Oncol (2001) 1.01
Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87/93 trials. Leukemia (2003) 1.00
Chromoconfusion: a new type of pill-pill "interaction" in cardiology. Can Med Assoc J (1974) 0.99
Letter: A survey of hospital pharmacists' knowledge of the content of drug combinations. Ann Intern Med (1975) 0.99
Prognostic value of plasma renin activity in renovascular hypertension. Circulation (1967) 0.98
[Surveillance of metformin]. Union Med Can (1977) 0.98
Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate. Int J Radiat Oncol Biol Phys (2001) 0.98
[Rehabilitation of oral hypoglycemic agents]. Union Med Can (1975) 0.97
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults. J Clin Oncol (2000) 0.97
A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy. Blood (1998) 0.97
Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European Bone Marrow Transplant Group. Clin Infect Dis (1992) 0.97
Follow-up of neurocysticercosis patients after treatment using an antigen detection ELISA. Parasite (2003) 0.97
Properties of acebutolol in twenty patients with cardiac arrhythmias. Eur J Clin Pharmacol (1975) 0.96
Pulmonary extractionof bradykinin and eledoisin. Rev Can Biol (1968) 0.96
Pulmonary fate of vasoactive peptides in fetal, newborn, and adult sheep. Am J Physiol (1972) 0.96
Percutaneous injection of orthopedic cement in metastatic vertebral lesions. N Engl J Med (1989) 0.95
Familial aggregation of blood pressure in 558 adopted children. Can Med Assoc J (1976) 0.95
Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation. Lancet (1994) 0.94
Letter: Phenformin and the heart. Can Med Assoc J (1976) 0.94
Desmoplastic small round cell tumors of the abdomen. Cancer (1994) 0.94
Fate of vasopressin and oxytocin in the pulmonary circulation. Can J Physiol Pharmacol (1969) 0.94
High-dose carmustine for high-grade gliomas in childhood. Cancer Chemother Pharmacol (1997) 0.94
Diurnal variations of EEG power in healthy adults. Electroencephalogr Clin Neurophysiol (1995) 0.94
Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: preliminary results. Int J Radiat Oncol Biol Phys (2000) 0.94
Removal of angiotensins from the systemic circulation. Can J Physiol Pharmacol (1968) 0.93
Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991. Eur J Cancer (2009) 0.93